glp-1 agonist and allergic reaction Frontiers

Who should actually take a GLP-1? An obesity expert's honest take | Levels | Levels

GLP-1 receptor agonists How weight loss injections work

Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis

In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with

GLP-1 receptor agonists (such as Victoza and Ozempic) are medications originally developed for type 2 diabetes and obesity. They work by mimicking a natural hormone that regulates blood sugar and appetite, leading

Medications affect our bodies in many different ways. Research shows GLP-1 and GIP Agonists used for weight loss can cause Shedding or telogen effluvium, new studies show these drugs can also cause